Met Life Investment Management, LLC Atreca, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$7.82 - $13.8 $36,206 - $63,894
-4,630 Closed
0 $0
Q1 2021

May 17, 2024
BUY
$13.0 - $19.34 $60,190 - $89,544
4,630 New
4,630 $70,000
Q1 2021

Jun 26, 2023
BUY
$13.0 - $19.34 $60,190 - $89,544
4,630 New
4,630 $71 Million
Q1 2021

Mar 22, 2023
SELL
$13.0 - $19.34 $99,970 - $148,724
-7,690 Reduced 62.42%
4,630 $70,000
Q1 2021

May 14, 2021
SELL
$13.0 - $19.34 $99,970 - $148,724
-7,690 Reduced 62.42%
4,630 $71,000
Q4 2020

Jun 22, 2023
BUY
$13.03 - $17.09 $160,529 - $210,548
12,320 New
12,320 $198,000
Q3 2020

Jun 26, 2023
BUY
$12.67 - $23.19 $156,094 - $285,700
12,320 New
12,320 $172,000
Q2 2020

May 24, 2024
BUY
$12.52 - $23.45 $154,246 - $288,904
12,320 New
12,320 $262 Million
Q2 2020

Jun 26, 2023
BUY
$12.52 - $23.45 $154,246 - $288,904
12,320 New
12,320 $262,000
Q2 2020

Mar 22, 2023
BUY
$12.52 - $23.45 $48,878 - $91,548
3,904 Added 46.39%
12,320 $262,000
Q2 2020

Aug 14, 2020
BUY
$12.52 - $23.45 $48,878 - $91,548
3,904 Added 46.39%
12,320 $262,000
Q1 2020

Jul 12, 2023
BUY
$11.4 - $27.28 $95,942 - $229,588
8,416 New
8,416 $139,000
Q1 2020

Mar 22, 2023
BUY
$11.4 - $27.28 $95,942 - $229,588
8,416 New
8,416 $139,000
Q1 2020

May 15, 2020
BUY
$11.4 - $27.28 $95,942 - $229,588
8,416 New
8,416 $139,000

Others Institutions Holding BCEL

# of Institutions
2
Shares Held
30.6K
Call Options Held
0
Put Options Held
0
View Full List

About Atreca, Inc.

BCEL Quotes by TradingView
  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email